DNA repair polymorphisms influence the risk of second neoplasm after treatment of childhood acute lymphoblastic leukemia

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 11, 2012, Pages 1919-1930

  Erčulj, Nina ^a   Faganel Kotnik, Barbara ^b   Debeljak, Maruša ^b   Jazbec, Janez ^b   Dolžan, Vita ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

Author keywords

Childhood acute lymphoblastic leukemia; DNA repair; Polymorphisms; Second neoplasm

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN; EPIPODOPHYLLOTOXIN; ETOPOSIDE; TENIPOSIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; ASTROCYTOMA; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; FEMALE; FIBROSARCOMA; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLIOBLASTOMA; HEREDITY; HETEROZYGOTE; HODGKIN DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NBN GENE; NONHODGKIN LYMPHOMA; OLIGODENDROGLIOMA; OSTEOSARCOMA; PARATHYROID CARCINOMA; PAROTID GLAND CARCINOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RAD51 GENE; RADIATION DOSE; RISK FACTOR; SCHOOL CHILD; SECOND CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; SLOVENIA; STEM CELL TRANSPLANTATION; UTERUS CARCINOMA; WHOLE BODY RADIATION; WILD TYPE; XRCC1 GENE; XRCC3 GENE;

ADOLESCENT; ALLELES; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; MALE; NEOPLASMS, SECOND PRIMARY; NUCLEAR PROTEINS; PODOPHYLLOTOXIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RADIOTHERAPY; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84870447189     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1265-4     Document Type: Article

References (57)

1. Allen-Brady K, Wong J, Camp NJ (2006) PedGenie: an analysis approach for genetic association testing in extended pedigrees and genealogies of arbitrary size. BMC Bioinformatics 7:209. doi:10.1186/1471-2105-7-209
2. Bhatia S, Sather HN, Pabustan OB, Trigg ME, Gaynon PS, Robison LL (2002) Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 99(12): 4257-4264 (Pubitemid 34627190)
3. Borgmann A, Zinn C, Hartmann R, Herold R, Kaatsch P, Escherich G, Moricke A, Henze G, von Stackelberg A (2008) Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. Eur J Cancer 44(2): 257-268. doi:10.1016/j.ejca.2007.09.019
4. Caldecott KW (2003) XRCC1 and DNA strand break repair. DNA Repair (Amst) 2(9): 955-969. doi:10.1016/S1568-7864(03) 00118-6 (Pubitemid 37088158)
5. Caldecott KW, Aoufouchi S, Johnson P, Shall S (1996) XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res 24(22): 4387-4394. doi:10.1093/nar/24.22.4387 (Pubitemid 26388624)
6. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem 267(1): 166-172
7. Erculj N, Kovac V, Hmeljak J, Dolzan V (2011) The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesothelioma. Ann Oncol. [Epub ahead of print Jul 15]. doi:10.1093/annonc/mdr324
8. Erculj N, Zadel M, Dolzan V (2010) Genetic polymorphisms in base excision repair in healthy Slovenian population and their influence on DNA damage. Acta Chim Slov 57(1): 182-188
9. Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11(12): 1513-1530 (Pubitemid 36020002)
10. Goricar K, Erculj N, Zadel M, Dolzan V (2011) Genetic polymorphisms in homologous recombination repair genes in healthy Slovenian population and their influence on DNA damage. Radiol Oncol. [E pub ahead of print], Jan 2. doi:10.2478/v10019-012-0001-7
11. Hawkins MM, Wilson LM, Stovall MA, Marsden HB, Potok MH, Kingston JE, Chessells JM (1992) Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. BMJ 304(6832): 951-958
12. Hijiya N, Hudson MM, Lensing S, Zacher M, Onciu M, Behm FG, Razzouk BI, Ribeiro RC, Rubnitz JE, Sandlund JT, Rivera GK, Evans WE, Relling MV, Pui CH (2007) Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 297(11): 1207-1215. doi: 10.1001/jama.297.11.1207 (Pubitemid 46465729)
13. Ho-Pun-Cheung A, Assenat E, Bascoul-Mollevi C, Bibeau F, Boissiere-Michot F, Thezenas S, Cellier D, Azria D, Rouanet P, Senesse P, Ychou M, Lopez-Crapez E (2011) A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer. Pharmacogenomics J 11(6): 437-443. doi:10.1038/tpj.2010.62
14. International HapMap Consortium. The International HapMap Project (2003). Nature 426 (6968): 789-796. doi:10.1038/nature02168 (Pubitemid 38056856)
15. Jawad M, Seedhouse CH, Russell N, Plumb M (2006) Polymorphisms in human homeobox HLX1 and DNA repair RAD51 genes increase the risk of therapy-related acute myeloid leukemia. Blood 108(12): 3916-3918. doi:10.1182/blood-2006-05- 022921 (Pubitemid 44864577)
16. Jazbec J, Aplenc R, Dolzan V, Debeljak M, Jereb B (2003) GST polymorphisms and occurrence of second neoplasms after treatment of childhood leukemia. Leukemia 17(12): 2540-2542. doi:10.1038/sj.leu.24031642403164 (Pubitemid 38072601)
17. Jazbec J, Ecimovic P, Jereb B (2004) Second neoplasms after treatment of childhood cancer in Slovenia. Pediatr Blood Cancer 42(7): 574-581. doi:10.1002/pbc.20025 (Pubitemid 38669744)
18. Jazbec J, Kitanovski L, Aplenc R, Debeljak M, Dolzan V (2005) No evidence of association of methylenetetrahydrofolate reductase polymorphism with occurrence of second neoplasms after treatment of childhood leukemia. Leuk Lymphoma 46(6): 893-897. doi:10.1080/10428190500086428 (Pubitemid 40959678)
19. Jazbec J, Rajic V, Karas-Kuzelicki N (2008) Leukemias of childhood. Zdravniski Vestnik-Slovenian Med J 77:I25-I30
20. Jazbec J, Todorovski L, Jereb B (2007) Classification tree analysis of second neoplasms in survivors of childhood cancer. BMC Cancer 7:27. doi:10.1186/1471-2407-7-27 (Pubitemid 46322355)
21. Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG (eds) (1991) Cancer registration: principles and methods. IARC Scientific Publications No. 95. International Agency for Research in Cancer, Lyon
22. Khanna KK, Jackson SP (2001) DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27(3): 247-254. doi: 10.1038/85798 (Pubitemid 32201842)
23. Kimball Dalton VM, Gelber RD, Li F, Donnelly MJ, Tarbell NJ, Sallan SE (1998) Second malignancies in patients treated for childhood acute lymphoblastic leukemia. J Clin Oncol 16(8): 2848-2853 (Pubitemid 28363051)
24. Loning L, Zimmermann M, Reiter A, Kaatsch P, Henze G, Riehm H, Schrappe M (2000) Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood 95(9): 2770-2775 (Pubitemid 30235882)
25. Maule M, Scelo G, Pastore G, Brennan P, Hemminki K, Tracey E, Sankila R, Weiderpass E, Olsen JH, McBride ML, Brewster DH, Pompe-Kirn V, Kliewer EV, Chia KS, Tonita JM, Martos C, Jonasson JG, Merletti F, Boffetta P (2007) Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. J Natl Cancer Inst 99(10): 790-800. doi: 10.1093/jnci/djk180 (Pubitemid 47073525)
26. Moricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dordelmann M, Loning L, Beier R, Ludwig WD, Ratei R, Harbott J, Boos J, Mann G, Niggli F, Feldges A, Henze G, Welte K, Beck JD, Klingebiel T, Niemeyer C, Zintl F, Bode U, Urban C, Wehinger H, Niethammer D, Riehm H, Schrappe M (2008) Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 111(9): 4477-4489. doi:10.1182/blood-2007-09-112920
27. Mosor M, Ziolkowska I, Januszkiewicz-Lewandowska D, Nowak J (2008) Polymorphisms and haplotypes of the NBS1 gene in childhood acute leukaemia. Eur J Cancer 44(15): 2226-2232. doi: 10.1016/j.ejca.2008.06.026
28. Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL (2001) Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 93(8): 618-629. doi:10.1093/jnci/93.8.618 (Pubitemid 32409629)
29. Neglia JP, Meadows AT, Robison LL, Kim TH, Newton WA, Ruymann FB, Sather HN, Hammond GD (1991) Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 325(19): 1330-1336. doi:10.1056/NEJM19911 1073251902
30. Ohnishi K, Scuric Z, Schiestl RH, Okamoto N, Takahashi A, Ohnishi T (2006) siRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status. Radiat Res 166(3): 454-462. doi:10.1667/RR3606.1 (Pubitemid 44353428)
31. Ott K, Rachakonda PS, Panzram B, Keller G, Lordick F, Becker K, Langer R, Buechler M, Hemminki K, Kumar R (2011) DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy. Ann Surg Oncol 18(9): 2688-2698. doi: 10.1245/s10434-011-1601-y
32. Pakakasama S, Sirirat T, Kanchanachumpol S, Udomsubpayakul U, Mahasirimongkol S, Kitpoka P, Thithapandha A, Hongeng S (2007) Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 48(1): 16-20. doi:10.1002/pbc.20742 (Pubitemid 44871587)
33. Park SL, Bastani D, Goldstein BY, Chang SC, Cozen W, Cai L, Cordon-Cardo C, Ding B, Greenland S, He N, Hussain SK, Jiang Q, Lee YC, Liu S, Lu ML, Mack TM, Mao JT, Morgenstern H, Mu LN, Oh SS, Pantuck A, Papp JC, Rao J, Reuter VE, Tashkin DP, Wang H, You NC, Yu SZ, Zhao JK, Zhang ZF (2010) Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers. Carcinogenesis 31(7): 1264-1271. doi: 10.1093/carcin/bgq096
34. Pratt CB, George SL, Hannock ML, Hustu HO, Kun LE, Ochs JS (1998) Second malignant neoplasms in survivors of childhood acute lymphoblastic leukemia [abstract]. Pediatr Res 23:345a
35. Pui CH, Cheng C, Leung W, Rai SN, Rivera GK, Sandlund JT, Ribeiro RC, Relling MV, Kun LE, Evans WE, Hudson MM (2003) Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 349(7): 640-649. doi:10.1056/NEJMoa035091 (Pubitemid 36975996)
36. Pui CH, Evans WE (2006) Treatment of acute lymphoblastic leukemia. N Engl J Med 354(2): 166-178. doi:10.1056/NEJMra052603 (Pubitemid 43076714)
37. Pui CH, Ribeiro RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, Head DR, Behm FG, Mahmoud MH, Sandlund JT et al (1991) Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 325(24): 1682-1687. doi:10.1056/NEJM199112123252402
38. Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D et al (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84(9): 3122-3133 (Pubitemid 24328106)
39. Riehm H, Reiter A, Schrappe M, Berthold F, Dopfer R, Gerein V, Ludwig R, Ritter J, Stollmann B, Henze G (1987) Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klin Padiatr 199(3): 151-160. doi: 10.1055/s-2008-1026781 (Pubitemid 17079852)
40. Sandoval C, Pui CH, Bowman LC, Heaton D, Hurwitz CA, Raimondi SC, Behm FG, Head DR (1993) Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation. J Clin Oncol 11(6): 1039-1045 (Pubitemid 23163342)
41. Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W, Niemeyer C, Henze G, Feldges A, Zintl F, Kornhuber B, Ritter J, Welte K, Gadner H, Riehm H (2000) Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 95(11): 3310-3322 (Pubitemid 30428458)
42. Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das-Gupta E (2002) The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood 100(10): 3761-3766. doi:10.1182/blood-2002-04-1152 (Pubitemid 35303949)
43. Seedhouse C, Faulkner R, Ashraf N, Das-Gupta E, Russell N (2004) Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin Cancer Res 10(8): 2675-2680. doi:10.1158/1078-0432.CCR-03-0372 (Pubitemid 38509141)
44. Shah A, Coleman MP (2007) Increasing incidence of childhood leukaemia: a controversy re-examined. Br J Cancer 97(7): 1009-1012. doi:10.1038/sj.bjc. 6603946 (Pubitemid 47519299)
45. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29(1): 308-311. doi:10.1093/nar/29.1.308 (Pubitemid 32054478)
46. Stanulla M, Dynybil C, Bartels DB, Dordelmann M, Loning L, Claviez A, Schrappe M (2007) The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group. Haema-tologica 92(11): 1581-1582. doi:10.3324/haematol.10260 (Pubitemid 350144140)
47. Stanulla M, Schaeffeler E, Moricke A, Coulthard SA, Cario G, Schrauder A, Kaatsch P, Dordelmann M, Welte K, Zimmermann M, Reiter A, Eichelbaum M, Riehm H, Schrappe M, Schwab M (2009) Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Munster protocols. Blood 114(7): 1314-1318. doi:10.1182/blood-2008-12-193250
48. Thompson LH, West MG (2000) XRCC1 keeps DNA from getting stranded. Mutat Res 459(1): 1-18. doi:10.1016/S0921-8777(99) 00058-0 (Pubitemid 30085463)
49. Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hankinson SE, Hunter DJ (2004) XRCC2 and XRCC3 polymorphisms are not associated with risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 13(6): 1090-1091. doi:10.1093/carcin/ bgh126 (Pubitemid 38968049)
50. Tregouet DA, Garelle V (2007) A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 23(8): 1038-1039. doi:10.1093/bioinfor matics/btm058 (Pubitemid 47050595)
51. Vral A, Willems P, Claes K, Poppe B, Perletti G, Thierens H (2011) Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity. Mol Med Report 4(5): 901-912. doi:10.3892/mmr. 2011.523
52. Walter AW, Hancock ML, Pui CH, Hudson MM, Ochs JS, Rivera GK, Pratt CB, Boyett JM, Kun LE (1998) Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. J Clin Oncol 16(12): 3761-3767 (Pubitemid 29001527)
53. Wilson DM 3rd, Bohr VA (2007) The mechanics of base excision repair, and its relationship to aging and disease. DNA Repair (Amst) 6(4): 544-559. doi:10.1016/j.dnarep.2006.10.017 (Pubitemid 46357056)
54. Wu PE, Shen CY (2011) 'Hide-then-hit' to explain the importance of genotypic polymorphism of DNA repair genes in determining susceptibility to cancer. J Mol Cell Biol 3(1): 59-65. doi: 10.1093/jmcb/mjq054
55. Xu Z, Taylor JA (2009) SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 37(Web Server issue):W600-W605. doi:10.1093/nar/gkp290
56. Yanagisawa T, Urade M, Yamamoto Y, Furuyama J (1998) Increased expression of human DNA repair genes, XRCC1, XRCC3 and RAD51, in radioresistant human KB carcinoma cell line N10. Oral Oncol 34(6): 524-528. doi:10.1016/S1368-8375(98) 00045-1 (Pubitemid 28546869)
57. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, Wang HH, Yao A, Chen YT, Hsu CN (2006) FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 34(Web Server issue): W635-W641. doi:10.1093/nar/gkl236 (Pubitemid 44529848)